3 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 33511016 | AZD9291 Resistance Reversal Activity of a pH-Sensitive Nanocarrier Dual-Loaded with Chloroquine and FGFR1 Inhibitor in NSCLC. | 2021 Jan | 1 |
2 | 34077739 | Osimertinib-resistant NSCLC cells activate ERBB2 and YAP/TAZ and are killed by neratinib. | 2021 Aug | 1 |
3 | 31446643 | SHR-A1403, a novel c-mesenchymal-epithelial transition factor (c-Met) antibody-drug conjugate, overcomes AZD9291 resistance in non-small cell lung cancer cells overexpressing c-Met. | 2019 Nov | 2 |